Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Monday, March 11, 2019 at 4:00 PM to 4:30 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 13.06.16 in Vol 5, No 2 (2016): Apr-Jun

This paper is in the following e-collection/theme issue:

Works citing "Hemiablative Focal Low Dose Rate Brachytherapy: A Phase II Trial Protocol"

According to Crossref, the following articles are citing this article (DOI 10.2196/resprot.5433):

(note that this is only a small subset of citations)

  1. Hübner N, Shariat SF, Remzi M. Focal therapy of prostate cancer. Current Opinion in Urology 2018;28(6):550
    CrossRef
  2. Srougi V, Barret E, Nunes-Silva I, Baghdadi M, Garcia-Barreras S, Pierrat N, Rozet F, Galiano M, Sanchez-Salas R, Cathelineau X, Cosset J. Focal brachytherapy for localized prostate cancer: Urinary toxicity depends on tumor location. Brachytherapy 2017;16(5):988
    CrossRef